secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2026-07-29T20:10:29+00:00
Accession:  0000816956-26-000101
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q2 adjusted EPS $1.38 beats; raises FY2026 adjusted EPS guidance to $4.48-$4.60
--------------------------------------------------------------------------------

- Q2 sales $343.5M (+0.3% as reported); organic constant currency sales +6.0% excluding GI product exits.
- GAAP EPS $0.77 (+11.6%); adjusted EPS $1.38 (+20.0%), both include $0.21 IEEPA tariff refund benefit.
- Full-year 2026 adjusted EPS guidance raised to $4.48-$4.60 (prior $4.30-$4.45); organic constant currency growth guidance narrowed to 5.0%-6.0%.
- Appointed John E. Gallagher as CFO effective July 15, 2026; added Celine Martin and Jeff Mirviss to Board effective July 1.
- AirSeal Robotic Solution now indicated for use with Intuitive's da Vinci 5 platform (8 mm hex cannulas).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000081695626000101/0000816956-26-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000081695626000101/cnmd-20260729.htm
  HTML page:      https://secwatch.observer/filing/0000816956-26-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer